Using Circulating Tumor DNA to Predict Cancer Recurrence and Guide Therapy

A recent technology is being increasingly used (at least in a research setting) to detect recurrence of cancer. The technology analyzes blood samples for...

FDA approves second PARP inhibitor for germline BRCA-mutated Locally Advanced or...

Today, the FDA approvedĀ approved talazoparib (Talzenna), a drug of the PARP inhibitor class for breast cancer patients who possess harmful (or suspected harmful) BRCA2...

October is Breast Cancer Awareness month. This week is HBOC Week...

October is Breast Cancer Awareness Month. This week is National Hereditary Breast and Ovarian Cancer (HBOC) Week and Wednesday October 3, 2018 is Previvor...

Survey Reveals Patients With Metastatic Breast Cancer Face Major Financial Stress...

A new nationwide analysis of more than 1,000 people living with metastatic breast cancer from 41 states reveals significant cancer-related financial burden known as...

Triple Negative Breast Cancer Day is on March 8

March 3, 2018 is Triple-Negative Breast Cancer Day. We have known for a while that not all breast cancer is created equal. Most breast...
0FansLike
65FollowersFollow
148FollowersFollow

Recent Posts

Ask a Breast Question
Ask a Breast Question X